Skip to content

PERiX: Comparison of Efficacy Between Placement of Epidural Catheters X-ray Guided and LOS Technique

PERiX: Comparison of Efficacy Between Placement of Epidural Catheters X-ray Guided and LOS Technique: Outcome Influence on Patient Underwent Pancreatic Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03685370
Acronym
PERiX
Enrollment
154
Registered
2018-09-26
Start date
2017-03-01
Completion date
2019-09-30
Last updated
2018-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haemodynamic Instability, Pancreatic Cancer, Postoperative Complications, Postoperative Pain

Keywords

Epidural catheter, postoperative pain, LOS

Brief summary

The use of epidural catheters for postoperative analgesia in pancreatic surgery is recommended by the guidelines of the ERAS society. Some studies claim it may expose to hemodynamic alterations that may compromise outcome and increase postoperative complications, attributable to a malfunction of the catheter itself, often linked to a bad positioning, since this is usually positioned with LOS technique. Our hypothesis is that a positioning made using the radiographic guide the day before the intervention can significantly reduce the number of catheter's dysfunctions.

Detailed description

About 30% of epidural catheters are reported to have hypo or hyper functioning behaviour. This has and impact on postoperative pain control and can affect also surgical and global outcome since it is known that a malfunctional catheter carries an increased complication's rate. Our hypothesis is that rx-guided positioning can reduce the incidence of catheter malfunction afrom 30 to 15 %.

Interventions

PROCEDURELOS

placement of epidural catheters with LOS technique

PROCEDUREX-ray placement

placement of epidural catheters with x-ray guide

Sponsors

Azienda Ospedaliera Universitaria Integrata Verona
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* scheduled for open pancreatic surgery * ASA \< = 3

Exclusion criteria

* scoliosis * coagulation abnormalities * antiplatelet drugs (except ASA) * history of back surgery * anticipated need of ICU stay

Design outcomes

Primary

MeasureTime frameDescription
Incidence of catheters malfunctions in LOS and X-ray groupevery day until 7th postoperative daymalfunctional catheters are defined as following: * symptomatic hypotension due to epidural infusion * NRS \> 6 in the first postoperative day and NRS \> 4 in subsequent postoperative day * overt malpositioning: * rx evidence of catheter's tip under T10 during routine rx or TC * NRS \> 6 (due to pain at T7-10 dermatomers) with 5 cc/h catheter infusion and response to lidocaine 1% 6ml bolus (low tip) * NRS \> 6 (due to pain at T7-10 dermatomers) with 5 cc/h catheter infusion and NO response to lidocaine 1% 6ml bolus ( not in epidural space or very low tip) * evidence of catheter accidental removal Numerical Rating Scale (NRS) is used to assess pain. Patients self-report actual pain on 0 to 10 scale where 0 is no pain and 10 is the worst immaginable pain.

Secondary

MeasureTime frameDescription
Evaluate daily pain differences between groups: NRS (Numeric rating scale)every day until 7th postoperative dayParameter used -higher postoperative daily numeric rating scale (NRS) until catheter removal Numerical Rating Scale (NRS) is used to assess pain. Patients self-report actual pain on 0 to 10 scale where 0 is no pain and 10 is the worst immaginable pain.
Monitoring postoperative surgical complications between groupsat 30th postoperative dayComplications are considered as: * bleedings * infections * pancreatic fistulas (degree) * biliary fistulas * abdominal collections * ICU admission * needs of new surgery (for any reasons) * pneumonia * delayed gastric emptying

Countries

Italy

Contacts

Primary ContactAlvise Martini, MD
alvise.martini@univr.it0458124666

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026